Results 221 to 230 of about 3,606,413 (293)

Optimized Adsorption of Dyes and Antibiotics onto Natural Acacia Ataxacantha for Water Treatment

ACS Omega
Khaled Chawraba, Wassim El Malti, Assil Akil, Malak Hamieh, Mohammad Hammoud, Digambara Patra, Joumana Toufaily, Akram Hijazi   +7 more
doaj   +1 more source

Optimized breath analysis: customized analytical methods and enhanced workflow for broader detection of VOCs. [PDF]

Metabolomics
Arulvasan W, Greenwood J, Ball ML, Chou H, Coplowe S, Birch O, Gordon P, Ratiu A, Lam E, Tardelli M, Szkatulska M, Swann S, Levett S, Mead E, van Schooten FJ, Smolinska A, Boyle B, Allsworth M.   +17 more
europepmc   +1 more source

Perspectives in educating molecular pathologists on liquid biopsy: Toward integrative, equitable, and decentralized precision oncology

Molecular Oncology, EarlyView.
Liquid biopsy enables minimally invasive, real‐time molecular profiling through analysis of circulating biomarkers in biological fluids. This Perspective highlights the importance of training pathologists through integrative educational programs, such as the European Masters in Molecular Pathology, to ensure effective and equitable implementation of ...
Marius Ilié, Umberto Malapelle, Catherine Alix‐Panabières, Claus Lindbjerg Andersen, Sandra Chlebowski, Vivien Lake, Caroline Lacoux, Virginie Lespinet‐Fabre, Olivier Bordone, Simon Heeke, Christophe Bontoux, Ellen Heitzer, Klaus Pantel, Paul Hofman   +13 more
wiley   +1 more source

A Practical Framework for ASFV Disinfectant Evaluation: Differentiating Cytopathic Effects from Cytotoxicity via Integrated Analytical Methods. [PDF]

Pathogens
Song S, Shin KS, Kim SJ, Joo YY, Han B, Park SH, Ku HO, Jeong W, Park CK.   +8 more
europepmc   +1 more source

Transcriptional network analysis of PTEN‐protein‐deficient prostate tumors reveals robust stromal reprogramming and signs of senescent paracrine communication

Molecular Oncology, EarlyView.
Combining PTEN protein assessment and transcriptomic profiling of prostate tumors, we uncovered a network enriched in senescence and extracellular matrix (ECM) programs associated with PTEN loss and conserved in a mouse model. We show that PTEN‐deficient cells trigger paracrine remodeling of the surrounding stroma and this information could help ...
Ivana Rondon‐Lorefice, Jose I. Lopez, Aitziber Ugalde‐Olano, Maite Zufiaurre, Ianire Astobiza, Natalia Martin‐Martin, Laura Bozal‐Basterra, Saioa Garcia‐Longarte, Amaia Zabala‐Letona, Sofia Rey, Aida Santos‐Martin, Miguel Unda, Ana Loizaga‐Iriarte, Mariona Graupera, Paolo Nuciforo, Arkaitz Carracedo, Isabel Mendizabal   +16 more
wiley   +1 more source

Analytical Methods for Assessing Thiol Antioxidants in Biological Fluids: A Review. [PDF]

Molecules
Poimenova IA, Sozarukova MM, Ratova DV, Nikitina VN, Khabibullin VR, Mikheev IV, Proskurnina EV, Proskurnin MA.   +7 more
europepmc   +1 more source

Next‐generation proteomics improves lung cancer risk prediction

Molecular Oncology, EarlyView.
This is one of very few studies that used prediagnostic blood samples from participants of two large population‐based cohorts. We identified, evaluated, and validated an innovative protein marker model that outperformed an established risk prediction model and criteria employed by low‐dose computed tomography in lung cancer screening trials.
Megha Bhardwaj, Clara Frick, Ben Schöttker, Bernd Holleczek, Hermann Brenner   +4 more
wiley   +1 more source

Rapid detection of illegal selective androgen receptor modulators in unregistered supplements using a combination of selected solid-state analytical methods. [PDF]

ADMET DMPK
Jendrzejewska I, Cehlarik L, Goryczka T, Pietrasik E, Pawlik N, Jampilek J.   +5 more
europepmc   +1 more source

Effective therapeutic targeting of CTNNB1‐mutant hepatoblastoma with WNTinib

Molecular Oncology, EarlyView.
WNTinib, a Wnt/CTNNB1 inhibitor, was tested in hepatoblastoma (HB) experimental models. It delayed tumor growth and improved survival in CTNNB1‐mutant in vivo models. In organoids, WNTinib outperformed cisplatin and showed enhanced efficacy in combination therapy, supporting its potential as a targeted treatment for CTNNB1‐mutated HB.
Ugne Balaseviciute, Júlia Huguet‐Pradell, Jordi Abril‐Fornaguera, Albert Gris‐Oliver, Alex Rialdi, Elisa Fernández‐Martínez, Carla Montironi, Vanessa Del Pozo, Peter Houghton, Laura Zanatto, Agavni Mesropian, Ieva Keraite, Swan Thung, Carolina Armengol, Pau Sancho‐Bru, Ernesto Guccione, Roser Pinyol, Josep M. Llovet   +17 more
wiley   +1 more source

Validation Study of Analytical Methods for Multiparameter Flow Cytometry-Based Measurable Residual Disease Assessment in Acute Myeloid Leukemia. [PDF]

Int J Mol Sci
Barone M, Patuelli A, Dicataldo M, Irno Consalvo M, Chirumbolo G, Bandini L, Atzeni G, Forte D, Cristiano G, Ottaviani E, Curti A, Buccisano F, Catani L, Arpinati M.   +13 more
europepmc   +1 more source